For the past three decades, collaborations, deals and best practice exchanges on innovation and commercialisation have been a ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

Eli Lilly has unveiled plans to expand its long-standing partnership with Purdue University, with the drugmaker investing up ...

Alchemab Therapeutics has entered into a licensing agreement with Eli Lilly to develop and market ATLX-1282, a therapy candidate for amyotrophic lateral sclerosis (ALS) and other neurodegenerative ...

Eli Lilly and Purdue University, US, have announced the widening of their existing partnership with a planned investment of up to $250m.

Languages: English It's been eight days since siblings Lilly and Jack Sullivan were reported missing by their mother in rural Canada, with no sightings of the two. The Royal Canadian Mounted ...

At Goodyear, Ledbetter started out in 1979 slinging tires on the factory floor. She then climbed the managerial ladder, only to keep getting knocked back down. Her work record was top drawer, but ...

INDIANAPOLIS — Indianapolis-based pharmaceutical giant Eli Lilly and Company will invest up to $250 million as part of an expanded partnership with Purdue University announced Friday, May 9. The ...

Eli Lilly is investing more in its home state of Indiana, pumping up to $250 million more into an existing collaboration with Purdue University over the next eight years. The boosted pact with the ...

Alchemab Therapeutics has entered into a licensing agreement with Eli Lilly and Company (Lilly) for ATLX-1282, Alchemab’s first-in-class IND-ready programme for amyotrophic lateral sclerosis (ALS) and ...

Eli Lil­ly is set to pay up to $415 million in an ALS deal with Alchemab Therapeutics ... A federal judge sided with the FDA over its decision last year to remove Lilly’s GLP-1 drug tirzepatide from ...